Rocket Doctor Takes Center Stage in Inaugural NASCAR Cup Series Race at Naval Base Coronado as Primary Partner of Rick Ware Racing

Vancouver, BC, June 18, 2026 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality, affordable care, today announced the first activation of its national motorsports marketing partnership with Rick Ware Racing and FinTekk AP. Rocket Doctor AI will serve as the primary sponsor of Rick Ware Racing’s No. 51 Chevrolet, driven by Cody Ware in the inaugural Anduril 250 NASCAR Cup Series race Sunday at Qualcomm Circuit on Naval Base Coronado in San Diego.

SPIRIT BLOCKCHAIN CAPITAL ANNOUNCES SHARES FOR SERVICES ISSUANCE

Vancouver, BC, June 18, 2026 (GLOBE NEWSWIRE) — Spirit Blockchain Capital Inc. (CSE: SPIR) (“Spirit” or the “Company”), a Canadian-based publicly listed company focused on blockchain infrastructure and digital asset opportunities, is pleased to announce that its Board of Directors has approved the issuance of common shares to certain consultants and strategic advisors in recognition of services provided to the Company.

QS 2027, new record for Politecnico di Milano: 87th in the world and first in Italy

After entering the Top 100, the University gains a further 11 places and enters the world’s top 90 universities for the first time. Employability, global engagement, sustainability and research impact stand out

After entering the Top 100, the University gains a further 11 places and enters the world’s top 90 universities for the first time. Employability, global engagement, sustainability and research impact stand out

Memo Therapeutics AG Presents Complete Phase II Clinical Trial Data for Potravitug in Kidney Transplant Recipients at the American Transplant Congress 2026

Schlieren / Zurich, Switzerland, 18 June, 2026 – Memo Therapeutics AG (“MTx”), a late-stage biotech company translating unique immune responses into superior medicines to treat viral infections and cancer, announces the presentation of data from its Phase II clinical trial of potravitug at the American Transplant Congress (ATC) 2026, taking place from 20-24 June in Boston, USA.

Essential Pharma appoints Becki Morison as Chief Executive Officer

Egham, UK – 18 June 2026 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the appointment of Becki Morison as Chief Executive Officer, with effect from 1 July 2026. Becki succeeds Simon Ball, who has served as interim CEO since November 2025 and will continue in his role as President of the Company’s Rare Disease business unit.